StimCell Enegetics

StimCell Enegetics EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of StimCell Enegetics (STME) as of Oct 29, 2026 is -22.29. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -47.40 — a change of -52.98% (higher).

EV/FCF

-22.29

YoY

-52.98%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of StimCell Enegetics is 2026 -22.29 . EV/FCF (Enterprise Value to Free Cash Flow) of StimCell Enegetics was 2025 -47.40 . It decreases by -52.98% higher compared to the previous year.

The StimCell Enegetics EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2019
-21.72 USD
Jan 1, 2020
-7.24 USD
Jan 1, 2021
-12.21 USD
Jan 1, 2022
-13.91 USD
Jan 1, 2023
-26.34 USD
Jan 1, 2024
-44.81 USD
Jan 1, 2025
-47.40 USD
Jan 1, 2026
-22.29 USD
The StimCell Enegetics EV/FCF history
YEAREV/FCFYoY
-22.29-52.98%
-47.40+5.78%
-44.81+70.11%
-26.34+89.37%
-13.91+13.90%
-12.21+68.58%
-7.24-66.65%
-21.72+53.10%
-14.19+81.91%
-7.80-30.55%
-11.23-40.82%
-18.98-88.64%
-167.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

StimCell Enegetics Stock analysis

What does StimCell Enegetics do? Cell MedX Corp. makes money through its subsidiary Avyonce Cosmedics Inc., which resells spa technology and equipment to the beauty and wellness industry. Avyonce also markets eBalance Technology, used for micro current treatments targeting diabetes and related ailments, and conducts observational studies with this technology. The company provides continuing education for estheticians and healthcare professionals in medical aesthetics. Avyonce Cosmedics Inc. serves the beauty and wellness industry, focusing on professionals who use spa technology and equipment. The firm develops a family of devices based on eBalance Technology, which is applied in treatments for diabetes and related conditions. This technology is central to Avyonce's product offerings and educational services. Cell MedX Corp. operates as a development stage company with no full-time employees, relying on its subsidiary Avyonce to drive revenue. The company's business model centers on the commercialization of eBalance Technology through product sales, educational programs, and observational studies in the medical aesthetics sector. StimCell Enegetics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about StimCell Enegetics stock

EV/FCF (Enterprise Value to Free Cash Flow) of StimCell Enegetics is -22.29 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of StimCell Enegetics changed from -47.40 to -22.29, representing a -52.98% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) StimCell Enegetics since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s StimCell Enegetics with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — StimCell Enegetics

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — StimCell Enegetics